U.S. Gas Utilities Stock News

Tango Therapeutics (TNGX) is back in focus after reporting fourth quarter and full year 2025 results, outlining a funding runway beyond 2028, and signing a new clinical trial collaboration with Erasca for difficult cancers. See our latest analysis for Tango Therapeutics. The earnings update, extended funding runway and new Erasca collaboration appear to have coincided with building momentum, with the 30 day share price return of 37.19% and year to date share price return of 93.73% sitting...

If you are wondering whether e.l.f. Beauty's share price still reflects its true worth after a strong multi year run, looking closely at its valuation can help put the current price into context. The stock last closed at US$73.41, with returns of an 11% decline over the past 7 days, a 4.4% decline over 30 days, a 5.7% decline year to date, a 7.7% gain over 1 year, 1.3% over 3 years, and a very large gain over 5 years. Recent price moves sit against a backdrop of ongoing interest in e.l.f...

If you are wondering whether Chemed is attractively priced after a tough stretch, this article walks through what the current share price may be implying about its value. The stock closed at US$401.87, with returns of a 1.5% decline over 7 days, 13.2% decline over 30 days, 5.2% decline year to date, 32.5% decline over 1 year, 21.0% decline over 3 years and 9.6% decline over 5 years. This performance may change how investors think about its risk and return trade off. Recent coverage around...

In recent days, Magnolia Oil & Gas reported an 11% increase in proved developed producing reserves, fourth-quarter net income of US$71.4 million, and year-on-year production growth to 103,800 barrels of oil equivalent per day. At the same time, insider share sales and a new 52-week high coincided with analysts highlighting Magnolia’s stronger reserve base and operational efficiency amid shifting geopolitical conditions for oil markets. We’ll now examine how Magnolia’s improved reserves and...

Lazard (LAZ) has been caught in a sector wide selloff, as geopolitical tensions, higher crude prices, and JPMorgan’s lending pullback to private credit providers have fueled liquidity worries and pressured financial stocks. See our latest analysis for Lazard. At a share price of US$40.53, Lazard has seen a 1 day share price return of 0.37% decline, a 7 day share price return of 9.21% decline, and a 30 day share price return of 26.03% decline. Its 1 year total shareholder return of 5.99%...

Why Warner Bros. Discovery Stock Is on Investors’ Radar Warner Bros. Discovery (WBD) continues to attract attention as investors weigh its recent share performance, with the stock showing a 1 day return of 1.06% and a past 3 months return of 9.47%. Those moves sit alongside a reported US$37.3b in revenue and US$728m in net income. This has prompted many to reassess how the media group’s Streaming, Studios, and Global Linear Networks segments stack up at the current US$27.14 share price. See...

In March 2026, Bumble reported fourth-quarter 2025 results that exceeded revenue and earnings expectations, issued first-quarter 2026 revenue guidance of US$209 million to US$213 million (including US$171 million to US$174 million from the Bumble app), and highlighted stronger profitability despite fewer paying users. The company also unveiled an AI-powered overhaul, including its Bee model, the Dates assistant and the upcoming Bumble 2.0 cloud-native platform, aiming to improve user...

Why Perrigo’s UBS conference appearance is drawing fresh attention Perrigo (PRGO) is set to present at the UBS Global Consumer and Retail Conference in New York on March 11, 2026, with President and CEO Patrick Lockwood-Taylor scheduled to speak. The event has put a fresh spotlight on the stock, as investors look for updated commentary on Perrigo’s over the counter health and wellness portfolio, recent financial results, and how management is thinking about capital allocation. See our latest...

Aptiv’s board has approved the spin-off of its Electrical Distribution Systems business into a new, independent public company called Versigent, and its subsidiary Aptiv Swiss Holdings has launched a cash tender offer of up to US$1.35 billion for outstanding notes, contingent on completing the separation and receiving at least US$1.70 billion in special dividends from Versigent. By pairing the Versigent spin-off with new bond issuances and a sizable tender offer, Aptiv is actively reshaping...

In early March 2026, a federal Medicare regulator warned Elevance Health that it may face intermediate sanctions over alleged noncompliance with risk‑adjustment and data submission rules, potentially halting new enrollments for certain Medicare Advantage prescription drug plans if issues are not resolved. At the same time, Elevance Health reaffirmed its 2026 earnings and benefit expense guidance and expanded clinical partnerships such as Myomo’s orthotic device coverage, highlighting a...

In March 2026, Palantir Technologies and partners including Ondas, World View, GE Aerospace, Centrus Energy, LG CNS, NVIDIA, and Polymarket announced a wave of collaborations applying Palantir’s AI platforms to defense, aerospace, industrial operations, sovereign AI data centers, and sports integrity monitoring. These agreements highlight Palantir’s push to embed its Artificial Intelligence Platform and related software as core infrastructure across high-stakes sectors, from military...

If you are looking at Humana and wondering whether the recent share price puts it in bargain territory or not, it helps to start with the facts behind the current valuation story. Humana's share price most recently closed at US$165.43, with returns of a 7.7% decline over 7 days, a 5.7% decline over 30 days, a 37.5% decline year to date, a 33.7% decline over 1 year, a 65.5% decline over 3 years, and a 57.7% decline over 5 years. Recent headlines around Humana have focused on how the share...

In recent weeks, Merit Medical Systems faced a shift in Wall Street opinion when Wells Fargo downgraded its rating, prompting a period of sustained institutional selling despite no major operational changes. What stands out is that the company’s underlying operations and financial health remain solid, suggesting investor sentiment has moved more than the business fundamentals. We’ll now explore how Wells Fargo’s downgrade and the resulting sentiment shift may influence Merit Medical...

Weather hit, guidance cut: why Vail Resorts stock is back in focus Vail Resorts (MTN) is under the spotlight after one of the weakest snowfall seasons in over 30 years led to fewer skier visits, softer revenue across business lines, and a cut to 2026 earnings guidance. See our latest analysis for Vail Resorts. Those weather headwinds and the cut to 2026 guidance have weighed on sentiment, with a 90 day share price return of 18.56% and a 1 year total shareholder return of 12.46% in decline...

If you are wondering whether Knight-Swift Transportation Holdings is attractively priced today, you are not alone. Its recent share performance has put valuation questions front and center. The stock last closed at US$51.93, with a 7 day return of an 8.7% decline, a 30 day return of a 13.8% decline and a 1 year return of 13.3%, which gives mixed signals on how the market is treating the company right now. Recent news around Knight-Swift has focused on its position in the US trucking and...

AeroVironment (AVAV) shares came under pressure after third quarter results missed earnings and revenue expectations, included a large goodwill impairment tied to the Space Force SCAR contract, and prompted lower full year guidance. See our latest analysis for AeroVironment. At a share price of $207.07, AeroVironment has had a 1 day share price return of a 2.27% decline and a 30 day share price return of a 14.93% decline. Its 1 year total shareholder return of 59.96% shows longer term holders...

Warrior Met Coal recently began commercial-scale mining at its Blue Creek project ahead of schedule, which has already started to influence revenue and cash flow expectations based on higher production capacity. This early ramp-up at Blue Creek is reshaping views on the company’s future operations, including potential shifts in capital spending needs and shareholder cash distributions. Next, we’ll explore how the ahead-of-schedule Blue Creek commercial production may affect Warrior Met...

If you are wondering whether Amentum Holdings at US$27.90 is offering fair value or an opportunity, you are not alone in asking what the current price really reflects. The stock has seen a mixed return profile, with a 7% decline over the last week and an 8.2% decline over the last month, while still sitting on a 55.9% return over the past year and an 8.5% decline year to date. Recent news coverage around Amentum has focused on its position in the commercial services space and how investors...

What Deckers Outdoor’s recent share performance tells you Deckers Outdoor (DECK) has drawn attention after a mixed stretch in its share performance, with a small 1-day gain contrasting with weaker moves over the past week, month, and past 3 months. Over the past week the stock shows a 3.3% decline, with a 12.6% decline over the past month and a marginal 0.4% decline over the past 3 months. Year to date, the total return stands at a 5.6% decline, while the 1 year total return shows a 15.1%...

Recent performance snapshot Simon Property Group (SPG) has given investors a mixed price picture recently, with a roughly 0.4% decline over the past day and about 4.1% over the week and month, but a gain over the past 3 months. At a last close of US$186.82, the real estate investment trust sits against a backdrop of annual revenue of US$6,364.505m and net income of US$4,624.275m, alongside a value score of 5. See our latest analysis for Simon Property Group. That recent 1-month share price...

If you are wondering whether Guidewire Software's share price still reflects its true worth after a strong multi year run, this article will walk you through what the numbers are saying about value today. The stock currently trades at US$160.57, with returns of 23.1% over the last 30 days, a 4.9% decline over the last week, and longer term returns of 108.0% over 3 years and 56.0% over 5 years, alongside declines of 14.4% year to date and 13.6% over 1 year. These moves have kept Guidewire on...

On March 11, 2026, shareholder John Chevedden submitted a proposal at The Sherwin-Williams Company to lower the ownership threshold required for investors to call a special shareholder meeting, while the board urged shareholders to vote against it at the April 22, 2026 annual meeting. This clash over special meeting rights highlights ongoing tension between Sherwin-Williams’ management and activist investors regarding how much direct influence shareholders should have over corporate...

Reformulation demand reshapes the story for Ingredion (INGR) Ingredion (INGR) is responding to rising demand from food and beverage companies that want higher protein, less sugar, and cleaner labels, becoming more selective about partnerships and leaning on its rapid reformulation capabilities. See our latest analysis for Ingredion. Against this reformulation push, Ingredion’s share price has eased over the past month, with a 30 day share price return of a 6.31% decline and a 1 year total...

AST SpaceMobile (ASTS) is back in focus after signing a commercial agreement with TELUS to roll out space based cellular broadband across Canada, while also reporting fresh quarterly results and updated growth plans. See our latest analysis for AST SpaceMobile. Even with the TELUS deal and Q4 headline revenue of US$54.31 million, recent trading has cooled, with a 30 day share price return of a 10.92% decline and a 7 day share price return of a 3.50% decline, set against a very large 1 year...